Artal Group’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-800,000	Closed	-$15.4M	–	59
2024 Q2	$15.4M	Hold	800,000	–	–	0.39%	27
2024 Q1	$18.9M	Buy	+800,000	New	+$18.9M	0.48%	27